Medmain

Minato, Japan Founded: 2018 • Age: 8 yrs
AI-based software for pathology image diagnosis is provided by Medmain.
Annual revenue - Latest available
Total funding $8.8M 2 rounds
Employees - Tracked headcount
Investors 7 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Medmain

Medmain is a company based in Minato (Japan) founded in 2018 by Osamu Iizuka. Medmain has raised $8.8 million across 2 funding rounds from investors including Nikon, Plug and Play Tech Center and Migalo. Medmain operates in a competitive market with competitors including Viz.ai, PathAI, Deepcell, Aignostics and Definiens, among others.

  • Headquarter Minato, Japan
  • Founders Osamu Iizuka
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $8.8 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.3 M (USD), Series A

    May 08, 2025

  • Investors
    Nikon

    & 6 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Medmain

Medmain has successfully raised a total of $8.8M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.3 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Medmain

Medmain has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Nikon, Plug and Play Tech Center and Migalo.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Startups are accelerated and invested in across multiple tech sectors.
Locked Locked Locked
Startups are incubated across sectors by One Capital.
Locked Locked Locked
Premium access

Investor details for Medmain

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Medmain

Investments
Premium access

Investment portfolio details for Medmain

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Medmain

Premium access

Detailed financials for Medmain

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Medmain Comparisons

Medmain Primary company
Description
AI-based software for pathology image diagnosis is provided ...
Location
Minato, Japan
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Medmain

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Medmain

Medmain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viz.ai, PathAI, Deepcell, Aignostics and Definiens, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI and cloud-powered software for stroke care coordination is developed.
Locked Locked Locked
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
Locked Locked Locked
AI-powered single cell classification and isolation technology for clinical research
Locked Locked Locked
AI-based pathology diagnostic software is provided for medical analysis.
Locked Locked Locked
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
Locked Locked Locked
Digital pathology software is developed for clinical and veterinary productivity.
Premium access

Detailed competitors of Medmain

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Medmain

Premium access

Complete news archive for Medmain

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medmain

Medmain was founded in 2018 and raised its 1st funding round 6 years after it was founded.

Medmain is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.

Osamu Iizuka is the current CEO of Medmain. They have also founded this company.

Medmain is a funded company, having raised a total of $8.8M across 2 funding rounds to date.

Medmain was established in 2018 in Minato City, Japan, within the healthcare technology sector. AI-driven analysis tools for pathology images are developed and supplied by the company. The Pidport platform facilitates rapid screening of tissues and cells from pathological samples. Image data and associated case details are handled and archived via cloud-based servers, supporting diagnostic workflows in medical settings.

Medmain's top competitors include Aignostics, Deciphex and Pictor Labs.

Medmain has 7 investors. Key investors include Nikon, Plug and Play Tech Center, Migalo, AngelNavi, and PSP.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available